Recent Patents on CNS Drug Discovery (Discontinued)

Editor-in-Chief:
Vincenzo Di Marzo
Istituto di Chimica Biomolecolare (I.C.B.)
Consiglio Nazionale delle Ricerche (C.N.R.)
Via Campi Flegrei 34
Pozzuoli, Napoli 80078
Italy

Back

Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders

Volume:5   Issue: 3
Pp: 182-194
Mariacristina Siotto, Serena Bucossi and Rosanna Squitti
DOI: 10.2174/157488910793362395

Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases

Volume:5   Issue: 3
Pp: 195-202
Antonio Martin, Giulia De Vivo, Mariangela Ricotta, Maura Iannuzzi and Vittorio Gentile
DOI: 10.2174/157488910793362430

Current Options in the Treatment of Mitochondrial Diseases

Volume:5   Issue: 3
Pp: 203-209
Mauro Scarpelli, Maria Sofia Cotelli, Michelangelo Mancuso, Giuliano Tomelleri, Paola Tonin, Carla Baronchelli, Valentina Vielmi, Valeria Gregorelli, Alice Todeschini, Alessandro Padovani and Massimiliano Filosto
DOI: 10.2174/157488910793362412

PTI-609: A Novel Analgesic that Binds Filamin A to Control Opioid Signaling

Volume:5   Issue: 3
Pp: 210-220
Lindsay H. Burns and Hoau-Yan Wang
DOI: 10.2174/157488910793362386

Pharmacological Therapy of Parkinson’s Disease: Current Options and New Avenues

Volume:5   Issue: 3
Pp: 221-238
Nicola Simola, Annalisa Pinna and Sandro Fenu
DOI: 10.2174/157488910793362421

Neurogenic Drugs and Compounds

Volume:5   Issue: 3
Pp: 253-257
Philippe Taupin
DOI: 10.2174/157488910793362377

Patent Selections: promotion: free to download

Volume:5   Issue: 3
Pp: 258-261
Bentham Science Publishers
DOI: 10.2174/157488910793362368